Clinical Trial

Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study is a single-center, randomized, open-label, two-period crossover design to evaluate the effect of food on the pharmacokinetic profile of ammoxetine hydrochloride enteric-coated tablets.
Trial Details
NCT Number NCT07508501
Lead Sponsor CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions Healthy Participants
Enrollment 14 participants
Start Date 2023-02-08
Primary Completion 2023-02-24 (estimated)
Study Completion 2023-04-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-02